
Live Cell Imaging Market Size, Share, and Analysis, By Product (Equipment, Consumables, Software, Services, and Others), By Application (Cell Biology, Stem Cells, Development Biology, Drug Discovery, and Others), By Technology (Time-Lapse Microscopy, Fluo
Description
Live Cell Imaging Market Size, Share, and Analysis, By Product (Equipment, Consumables, Software, Services, and Others), By Application (Cell Biology, Stem Cells, Development Biology, Drug Discovery, and Others), By Technology (Time-Lapse Microscopy, Fluorescence Resonance Energy Transfer (FRET), Fluorescence Recovery After Photobleaching (FRAP), High Content Screening, and Others ), By End-User (Academic and Research Institutes, Pharmaceutical and Biotechnological Companies, Contract Research Organisations and Others), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
PRODUCT OVERVIEW
Live Cell Imaging Market is projected to exhibit a Compound Annual Growth Rate (CAGR) of 9% during the forecast span from 2024 to 2034. In 2023, the market size was assessed at USD 2.7 billion and is projected to reach USD 6.9 billion by the completion of 2034.
Live cell imaging is a technique used to observe and analyze living cells in real time, allowing researchers to study cellular processes as they occur. This method employs specialized microscopes and imaging techniques such as fluorescence and confocal microscopy to capture dynamic cellular functions like movement, division, and interactions. Live cell imaging is crucial for understanding cell behavior, protein dynamics, and molecular interactions in their natural environment. It provides insights into processes such as cell signaling, gene expression, and drug responses, which are essential for advancing research in cell biology, medicine, and drug development. By preserving cell viability and enabling continuous observation, live cell imaging is a powerful tool for studying complex biological systems and mechanisms.
MARKET HIGHLIGHTS
Live Cell Imaging Market is expected to reach USD 6.9 billion during the forecast period, due to increasing R&D in cell biology and drug discovery. This growth is characterized by advances in imaging techniques, such as fluorescence microscopy and high-resolution live cell imaging systems, which enhance the precision and scope of cell studies. Key factors include the growing demand for personalized medicine, increased investments in biotechnology, and advancements in imaging techniques. However, the market faces challenges such as high equipment prices, complex data analysis requirements, and technical limitations in imaging resolution and cell processing. Addressing these challenges is crucial for market growth and technological development.
Live Cell Imaging Market Segments:
Growth Drivers
Advancements in Imaging Technologies is Expected to Foster Market Expansion
Increasing Research in Cell Biology is Anticipated to Stimulate Market Growth
Restraint
High Development Costs Can Limit the Growth of the Live Cell Imaging Market
Key Players
PRODUCT OVERVIEW
Live Cell Imaging Market is projected to exhibit a Compound Annual Growth Rate (CAGR) of 9% during the forecast span from 2024 to 2034. In 2023, the market size was assessed at USD 2.7 billion and is projected to reach USD 6.9 billion by the completion of 2034.
Live cell imaging is a technique used to observe and analyze living cells in real time, allowing researchers to study cellular processes as they occur. This method employs specialized microscopes and imaging techniques such as fluorescence and confocal microscopy to capture dynamic cellular functions like movement, division, and interactions. Live cell imaging is crucial for understanding cell behavior, protein dynamics, and molecular interactions in their natural environment. It provides insights into processes such as cell signaling, gene expression, and drug responses, which are essential for advancing research in cell biology, medicine, and drug development. By preserving cell viability and enabling continuous observation, live cell imaging is a powerful tool for studying complex biological systems and mechanisms.
MARKET HIGHLIGHTS
Live Cell Imaging Market is expected to reach USD 6.9 billion during the forecast period, due to increasing R&D in cell biology and drug discovery. This growth is characterized by advances in imaging techniques, such as fluorescence microscopy and high-resolution live cell imaging systems, which enhance the precision and scope of cell studies. Key factors include the growing demand for personalized medicine, increased investments in biotechnology, and advancements in imaging techniques. However, the market faces challenges such as high equipment prices, complex data analysis requirements, and technical limitations in imaging resolution and cell processing. Addressing these challenges is crucial for market growth and technological development.
Live Cell Imaging Market Segments:
- By Product
- Equipment
- Consumables
- Software
- Services
- Others
- By Application
- Cell Biology
- Stem Cells
- Development Biology
- Drug Discovery
- Others
- By Technology
- Time-Lapse Microscopy
- Fluorescence Resonance Energy Transfer (FRET)
- Fluorescence Recovery After Photobleaching (FRAP)
- High Content Screening
- Others
- By End-User
- Academic and Research Institutes
- Pharmaceutical and Biotechnological Companies
- Contract Research Organisations
- Others
Growth Drivers
Advancements in Imaging Technologies is Expected to Foster Market Expansion
Increasing Research in Cell Biology is Anticipated to Stimulate Market Growth
Restraint
High Development Costs Can Limit the Growth of the Live Cell Imaging Market
Key Players
- Nikon Corporation
- Olympus Corporation
- Leica Microsystems (Danaher Corporation)
- Thermo Fisher Scientific Inc.
- PerkinElmer, Inc.
- Carl Zeiss AG
- GE Healthcare
- BioTek Instruments
- Becton, Dickinson and Company (BD)
- Bruker Corporation
- Cytiva
- Yokogawa Electric Corporation
- Sartorius AG
- Molecular Devices
- Merck KGaA
- Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)
- North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAG.R – United States and Canada
- Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
- Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
- Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
- Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 3-month post-sales analyst support.
Table of Contents
646 Pages
- 1. Executive Summary
- 1.1. Regional Market Share
- 1.2. Business Trends
- 1.3. Live Cell Imaging Market: COVID-19 Outbreak
- 1.4. Regional Trends
- 1.5. Segmentation Snapshot
- 2. Research Methodology
- 2.1. Research Objective
- 2.2. Research Approach
- 2.3. Data Sourcing and Methodology
- 2.4. Primary Research
- 2.5. Secondary Research
- 2.5.1. Paid Sources
- 2.5.2. Public Sources
- 2.6. Market Size Estimation and Data Triangulation
- 3. Market Characteristics
- 3.1. Market Definition
- 3.2. Live Cell Imaging Market: COVID-19 Impact
- 3.3. Key Segmentations
- 3.4. Key Developments
- 3.5. Allied Industry Data
- 4. Live Cell Imaging Market – Industry Insights
- 4.1. Industry Segmentation
- 4.2. COVID-19 overview of world economy
- 4.3. Industry Ecosystem Channel Analysis
- 4.4. Innovation & Sustainability
- 5. Macroeconomic Indicators
- 6. Recent Developments
- 7. Market Dynamics
- 7.1. Introduction
- 7.2. Growth Drivers
- 7.3. Market Opportunities
- 7.4. Market Restraints
- 7.5. Market Trends
- 8. Risk Analysis
- 9. Market Analysis
- 9.1. Porter's Five Forces
- 9.2. PEST Analysis
- 9.2.1. Political
- 9.2.2. Economic
- 9.2.3. Social
- 9.2.4. Technological
- 10. Live Cell Imaging Market
- 10.1. Overview
- 10.2. Historical Analysis (2019-2022)
- 10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
- 11. Live Cell Imaging Market Size & Forecast 2024 A-2034 F
- 11.1. Overview
- 11.2. Key Findings
- 11.3. Market Segmentation
- 11.3.1. By Product
- 11.3.1.1. Equipment
- 11.3.1.1.1. By Value (USD Million) 2024-2034 F
- 11.3.1.1.2. Market Share (%) 2024-2034 F
- 11.3.1.1.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.1.2. Consumables
- 11.3.1.2.1. By Value (USD Million) 2024-2034 F
- 11.3.1.2.2. Market Share (%) 2024-2034 F
- 11.3.1.2.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.1.3. Software
- 11.3.1.3.1. By Value (USD Million) 2024-2034 F
- 11.3.1.3.2. Market Share (%) 2024-2034 F
- 11.3.1.3.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.1.4. Services
- 11.3.1.4.1. By Value (USD Million) 2024-2034 F
- 11.3.1.4.2. Market Share (%) 2024-2034 F
- 11.3.1.4.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.1.5. Others
- 11.3.1.5.1. By Value (USD Million) 2024-2034 F
- 11.3.1.5.2. Market Share (%) 2024-2034 F
- 11.3.1.5.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.2. By Application
- 11.3.2.1. Cell Biology
- 11.3.2.1.1. By Value (USD Million) 2024-2034 F
- 11.3.2.1.2. Market Share (%) 2024-2034 F
- 11.3.2.1.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.2.2. Stem Cells
- 11.3.2.2.1. By Value (USD Million) 2024-2034 F
- 11.3.2.2.2. Market Share (%) 2024-2034 F
- 11.3.2.2.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.2.3. Development Biology
- 11.3.2.3.1. By Value (USD Million) 2024-2034 F
- 11.3.2.3.2. Market Share (%) 2024-2034 F
- 11.3.2.3.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.2.4. Drug Discovery
- 11.3.2.4.1. By Value (USD Million) 2024-2034 F
- 11.3.2.4.2. Market Share (%) 2024-2034 F
- 11.3.2.4.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.2.5. Others
- 11.3.2.5.1. By Value (USD Million) 2024-2034 F
- 11.3.2.5.2. Market Share (%) 2024-2034 F
- 11.3.2.5.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.3. By Technology
- 11.3.3.1. Time-Lapse Microscopy
- 11.3.3.1.1. By Value (USD Million) 2024-2034 F
- 11.3.3.1.2. Market Share (%) 2024-2034 F
- 11.3.3.1.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.3.2. Fluorescence Resonance Energy Transfer (FRET)
- 11.3.3.2.1. By Value (USD Million) 2024-2034 F
- 11.3.3.2.2. Market Share (%) 2024-2034 F
- 11.3.3.2.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.3.3. Fluorescence Recovery After Photobleaching (FRAP)
- 11.3.3.3.1. By Value (USD Million) 2024-2034 F
- 11.3.3.3.2. Market Share (%) 2024-2034 F
- 11.3.3.3.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.3.4. High Content Screening
- 11.3.3.4.1. By Value (USD Million) 2024-2034 F
- 11.3.3.4.2. Market Share (%) 2024-2034 F
- 11.3.3.4.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.3.5. Others
- 11.3.3.5.1. By Value (USD Million) 2024-2034 F
- 11.3.3.5.2. Market Share (%) 2024-2034 F
- 11.3.3.5.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.4. By End-User
- 11.3.4.1. Academic and Research Institutes
- 11.3.4.1.1. By Value (USD Million) 2024-2034 F
- 11.3.4.1.2. Market Share (%) 2024-2034 F
- 11.3.4.1.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.4.2. Pharmaceutical and Biotechnological Companies
- 11.3.4.2.1. By Value (USD Million) 2024-2034 F
- 11.3.4.2.2. Market Share (%) 2024-2034 F
- 11.3.4.2.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.4.3. Contract Research Organisations
- 11.3.4.3.1. By Value (USD Million) 2024-2034 F
- 11.3.4.3.2. Market Share (%) 2024-2034 F
- 11.3.4.3.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.4.4. Others
- 11.3.4.4.1. By Value (USD Million) 2024-2034 F
- 11.3.4.4.2. Market Share (%) 2024-2034 F
- 11.3.4.4.3. Y-o-Y Growth (%) 2024-2034 F
- 12. North America Live Cell Imaging Market Size & Forecast 2024 A-2034 F
- 12.1. Overview
- 12.2. Key Findings
- 12.3. Market Segmentation
- 12.3.1. By Product
- 12.3.2. By Application
- 12.3.3. By Technology
- 12.3.4. By End-User
- 12.4. Country
- 12.4.1. United States
- 12.4.2. Canada
- 13. Europe Live Cell Imaging Market Size & Forecast 2024 A-2034 F
- 13.1. Overview
- 13.2. Key Findings
- 13.3. Market Segmentation
- 13.3.1. By Product
- 13.3.2. By Application
- 13.3.3. By Technology
- 13.3.4. By End-User
- 13.4. Country
- 13.4.1. Germany
- 13.4.2. United Kingdom
- 13.4.3. France
- 13.4.4. Italy
- 13.4.5. Spain
- 13.4.6. Russia
- 13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
- 14. Asia-Pacific Live Cell Imaging Market Size & Forecast 2024 A-2034 F
- 14.1. Overview
- 14.2. Key Findings
- 14.3. Market Segmentation
- 14.3.1. By Product
- 14.3.2. By Application
- 14.3.3. By Technology
- 14.3.4. By End-User
- 14.4. Country
- 14.4.1. India
- 14.4.2. China
- 14.4.3. South Korea
- 14.4.4. Japan
- 14.4.5. Rest of APAC
- 15. Middle East and Africa Live Cell Imaging Market Size & Forecast 2024 A-2034 F
- 15.1. Overview
- 15.2. Key Findings
- 15.3. Market Segmentation
- 15.3.1. By Product
- 15.3.2. By Application
- 15.3.3. By Technology
- 15.3.4. By End-User
- 15.4. Country
- 15.4.1. Israel
- 15.4.2. GCC
- 15.4.3. North Africa
- 15.4.4. South Africa
- 15.4.5. Rest of Middle East and Africa
- 16. Latin America Live Cell Imaging Market Size & Forecast 2024 A-2034 F
- 16.1. Overview
- 16.2. Key Findings
- 16.3. Market Segmentation
- 16.3.1. By Product
- 16.3.2. By Application
- 16.3.3. By Technology
- 16.3.4. By End-User
- 16.4. Country
- 16.4.1. Mexico
- 16.4.2. Brazil
- 16.4.3. Rest of Latin America
- 17. Competitive Landscape
- 17.1. Company market share, 2023
- 17.2. Key player overview
- 17.3. Key stakeholders
- 18. Company Profiles
- 18.1. Nikon Corporation
- 18.1.1. Company Overview
- 18.1.2. Financial Overview
- 18.1.3. Key Product; Analysis
- 18.1.4. Company Assessment
- 18.1.4.1. Product Portfolio
- 18.1.4.2. Key Clients
- 18.1.4.3. Market Share
- 18.1.4.4. Recent News & Development (Last 3 Yrs.)
- 18.1.4.5. Executive Team
- 18.2. Olympus Corporation
- 18.3. Leica Microsystems (Danaher Corporation)
- 18.4. Thermo Fisher Scientific Inc.
- 18.5. PerkinElmer, Inc.
- 18.6. Carl Zeiss AG
- 18.7. GE Healthcare
- 18.8. BioTek Instruments (Agilent Technologies)
- 18.9. Becton, Dickinson and Company (BD)
- 18.10. Bruker Corporation
- 18.11. Cytiva (formerly GE Healthcare Life Sciences)
- 18.12. Yokogawa Electric Corporation
- 18.13. Sartorius AG
- 18.14. Molecular Devices (Danaher Corporation)
- 18.15. Merck KGaA
- 18.16. Other Prominent Players
- 19. Appendix
- 20. Consultant Recommendation
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.